| A gene-expression signature as a predictor of survival in breast cancer MJ Van De Vijver, YD He, LJ Van't Veer, H Dai, AAM Hart, DW Voskuil, ... New England Journal of Medicine 347 (25), 1999-2009, 2002 | 8047 | 2002 |
| Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013 A Goldhirsch, EP Winer, AS Coates, RD Gelber, M Piccart-Gebhart, ... Annals of oncology 24 (9), 2206-2223, 2013 | 5050 | 2013 |
| Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015 AS Coates, EP Winer, A Goldhirsch, RD Gelber, M Gnant, ... Annals of oncology 26 (8), 1533-1546, 2015 | 2521 | 2015 |
| Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100 000 women in 123 randomised trials Early Breast Cancer Trialists' Collaborative Group The Lancet 379 (9814), 432-444, 2012 | 2461 | 2012 |
| 70-gene signature as an aid to treatment decisions in early-stage breast cancer F Cardoso, LJ van’t Veer, J Bogaerts, L Slaets, G Viale, S Delaloge, ... New England Journal of Medicine 375 (8), 717-729, 2016 | 2259 | 2016 |
| Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up E Senkus, S Kyriakides, S Ohno, F Penault-Llorca, P Poortmans, ... Annals of oncology 26, v8-v30, 2015 | 2258 | 2015 |
| Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition M Kriege, CTM Brekelmans, C Boetes, PE Besnard, HM Zonderland, ... New England Journal of Medicine 351 (5), 427-437, 2004 | 2243 | 2004 |
| Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority … M Donker, G van Tienhoven, ME Straver, P Meijnen, CJH van de Velde, ... The lancet oncology 15 (12), 1303-1310, 2014 | 2215 | 2014 |
| Effect of radiotherapy after mastectomy and axillary surgery on 10-year recurrence and 20-year breast cancer mortality: meta-analysis of individual patient data for 8135 women … P McGale, C Correa, D Cutter, F Duane, M Ewertz, R Gray, G Mannu, ... The Lancet 383 (9935), 2127-35, 2014 | 2194 | 2014 |
| Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009 A Goldhirsch, JN Ingle, RD Gelber, AS Coates, B Thürlimann, HJ Senn Annals of oncology 20 (8), 1319-1329, 2009 | 2015 | 2009 |
| Association analysis identifies 65 new breast cancer risk loci K Michailidou, S Lindström, J Dennis, J Beesley, S Hui, S Kar, A Lemaçon, ... Nature 551 (7678), 92-94, 2017 | 1691 | 2017 |
| Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer M Buyse, S Loi, L Van't Veer, G Viale, M Delorenzi, AM Glas, ... Journal of the National Cancer Institute 98 (17), 1183-1192, 2006 | 1572 | 2006 |
| De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017 G Curigliano, HJ Burstein, EP Winer, M Gnant, P Dubsky, S Loibl, ... Annals of Oncology 28 (8), 1700-1712, 2017 | 1459 | 2017 |
| Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials B Asselain, W Barlow, J Bartlett, J Bergh, E Bergsten-Nordström, J Bliss, ... The Lancet Oncology 19 (1), 27-39, 2018 | 1204 | 2018 |
| Customizing local and systemic therapies for women with early breast cancer: the St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021 HJ Burstein, G Curigliano, B Thürlimann, WP Weber, P Poortmans, ... Annals of oncology 32 (10), 1216-1235, 2021 | 834 | 2021 |
| Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized … N Bijker, P Meijnen, JL Peterse, J Bogaerts, I Van Hoorebeeck, J Julien, ... Journal of clinical oncology 24 (21), 3381-3387, 2006 | 824 | 2006 |
| Breast conserving therapy versus mastectomy for stage I–II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trial S Litière, G Werutsky, IS Fentiman, E Rutgers, MR Christiaens, ... The lancet oncology 13 (4), 412-419, 2012 | 767 | 2012 |
| Prediction of breast cancer risk based on profiling with common genetic variants N Mavaddat, PDP Pharoah, K Michailidou, J Tyrer, MN Brook, MK Bolla, ... Journal of the National Cancer Institute 107 (5), djv036, 2015 | 752 | 2015 |
| Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials Early Breast Cancer Trialists' Collaborative Group The Lancet 386 (10001), 1353-1361, 2015 | 746 | 2015 |
| Micrometastases or isolated tumor cells and the outcome of breast cancer M De Boer, CHM Van Deurzen, JAAM Van Dijck, GF Borm, PJ Van Diest, ... New England Journal of Medicine 361 (7), 653-663, 2009 | 647 | 2009 |
